D-0387-2021 Class III Terminated
FDA drug recall D-0387-2021 was initiated by Nomax Inc on April 13, 2021 and is designated Class III. Reason for recall: Subpotent Drug The recall status is terminated (terminated September 28, 2023). Affected quantity: 78 cartons.
Recall Details
- Product Type
- Drugs
- Report Date
- May 26, 2021
- Initiation Date
- April 13, 2021
- Termination Date
- September 28, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 78 cartons
Product Description
Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of 2 Strips Each), Manufactured by: Nomax, Inc, St. Louis, MO 63123, NDC: 51801-008-15
Reason for Recall
Subpotent Drug
Distribution Pattern
Nationwide USA
Code Information
LOT 13336 EXP 07/23